SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-001125
Filing Date
2024-01-09
Accepted
2024-01-09 16:08:30
Documents
1
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 7280
  Complete submission text file 0001127602-24-001125.txt   8797
Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Issuer) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 940 WINTER STREET PERKINELMER WALTHAM MA 02451
Business Address
Mock James M (Reporting) CIK: 0001736359 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38753 | Film No.: 24523338